As of 2025-04-24, the Intrinsic Value of NeonMind Biosciences Inc (NEON.CN) is -4.20 CAD. This NEON.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 0.14 CAD, the upside of NeonMind Biosciences Inc is -3,212.04%.
Based on its market price of 0.14 CAD and our intrinsic valuation, NeonMind Biosciences Inc (NEON.CN) is overvalued by 3,212.04%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -4.20 - -4.20 | -4.20 | -3,212.04% |
| P/E | (0.03) - (0.05) | (0.04) | -131.1% |
| DDM - Stable | (7.90) - (48.27) | (28.09) | -20905.7% |
| DDM - Multi | (6.97) - (34.91) | (11.82) | -8857.0% |
| Market Cap (mil) | 0.33 |
| Beta | 3.55 |
| Outstanding shares (mil) | 2.42 |
| Enterprise Value (mil) | 1.34 |
| Market risk premium | 5.50% |
| Cost of Equity | 8.50% |
| Cost of Debt | 5.00% |
| WACC | 5.02% |